Related Experiment Video

Updated: May 20, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

An integrated and disease-oriented growth factor-regulated signal transduction network

A Erol1

  • 1Erol Project Development House for the Disorders of Energy Metabolism, Silivri-Istanbul, Turkey. eroladnan@hotmail.com

Current Molecular Medicine
|July 28, 2012
PubMed

Insights

This perspective proposes an integrated model of cell proliferation signaling, linking Akt and Erk pathways with TSC1-TSC2 complex, mTORC1/2, and Wnt-β-catenin. This model aims to clarify molecular connections relevant to degenerative diseases.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Biochemistry

Background:

  • Akt and Erk pathways are critical for cell proliferation, interacting to regulate growth.
  • Existing models of cell growth and division signaling are incomplete or debated, particularly regarding mTORC2.
  • The TSC1-TSC2 complex integrates nutrient and mitogenic signals, but its interactions with new molecules like Pin1 and DAPK need clarification.

Purpose of the Study:

  • To propose an integrated signaling model for cell proliferation.
  • To link growth factor-activated signaling nodes, including Akt, Erk, and Wnt-β-catenin.
  • To provide molecular connections relevant to understanding degenerative diseases.

Main Methods:

  • This is a perspective paper, not an experimental study.
  • Literature review and synthesis of existing data on cell signaling pathways.
  • Conceptual modeling of integrated signaling networks.

Main Results:

  • An integrated model is proposed, connecting key signaling nodes involved in cell proliferation.
  • The model highlights the interplay between growth factor signaling, the TSC1-TSC2 complex, and the Wnt-β-catenin pathway.
  • Identifies gaps in knowledge regarding TSC complex interactions with Pin1 and DAPK.

Conclusions:

  • A comprehensive model is needed to understand the complex signaling networks governing cell proliferation.
  • Clarifying these pathways may offer insights into the molecular basis of degenerative diseases.
  • Further research is required to validate the proposed interactions and their roles in disease.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...